Enlivex R&D Spending Growth & History (ENLV)
Enlivex's r&d spending was $9.2M for fiscal 2025.
View full Enlivex company overviewEnlivex annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $9.2M | −$1.4M | −13.36% |
| 2024 | 2024-12-31 | $10.6M | −$8.4M | −44.12% |
| 2023 | 2023-12-31 | $19.0M | $319,000 | +1.71% |
| 2022 | 2022-12-31 | $18.7M | $5.8M | +45.12% |
| 2021 | 2021-12-31 | $12.9M | $6.8M | +111.65% |
| 2020 | 2020-12-31 | $6.1M | $482,000 | +8.60% |
| 2019 | 2019-12-31 | $5.6M | $1.6M | +39.65% |
| 2018 | 2018-12-31 | $4.0M | $2.3M | +137.32% |
| 2017 | 2017-12-31 | $1.7M | −$7.2M | −80.96% |
| 2016 | 2016-12-31 | $8.9M | $1.2M | +15.43% |
| 2015 | 2015-12-31 | $7.7M | $3.3M | +73.25% |
| 2014 | 2014-12-31 | $4.4M | $3.7M | +506.69% |
| 2013 | 2013-12-31 | $732,000 | $592,000 | +422.86% |
| 2012 | 2012-12-31 | $140,000 | — | — |
Enlivex quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $3.0M | −$390,000 | −11.41% |
| Q3 2025 | 2025-09-30 | $1.5M | — | — |
| Q2 2025 | 2025-06-30 | $2.1M | $142,000 | +7.10% |
| Q1 2025 | 2025-03-31 | $2.5M | — | — |
| Q4 2024 | 2024-12-31 | $3.4M | — | — |
| Q2 2024 | 2024-06-30 | $2.0M | −$3.0M | −60.30% |
| Q2 2023 | 2023-06-30 | $5.0M | $925,000 | +22.51% |
| Q2 2022 | 2022-06-30 | $4.1M | $1.6M | +61.87% |
| Q2 2021 | 2021-06-30 | $2.5M | $1.3M | +101.99% |
| Q2 2020 | 2020-06-30 | $1.3M | $561,000 | +80.60% |
| Q2 2019 | 2019-06-30 | $696,000 | — | — |
Enlivex r&d spending trends
Over the last five fiscal years, Enlivex's r&d spending increased from $6.1M to $9.2M, a change of $3.1M. The latest reported quarter, Q4 2025, shows $3.0M.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Enlivex source filings ↗